India’s Delay On Global Fund Grant Caused HIV Drug Shortages, Live Mint Reports

India’s “health ministry sat on a $187 million international grant offered to the National AIDS Control Programme (NACP) for some 18 months, causing drug shortages that left about one million HIV-positive Indians treated under the program without drugs and testing kits for at least five of those months,” Live Mint reports. The Global Fund to Fight AIDS, Tuberculosis and Malaria, which provided the grant, “has written a 20-page note charging the National AIDS Control Organization (NACO) and the ministry with endangering the lives of HIV patients across the country through the inaction,” according to the news service, which reviewed a copy of the note. In the memo, “the Global Fund said it would not allow civil society to be subjected to service interruptions ‘traceable to government decision-making,'” Live Mint writes. The news service ran its story without a “promised” statement from NACO, and the Global Fund “did not respond to questions Mint sent to the agency on November 18,” Live Mint notes. The news service summarizes the Global Fund note and includes comments from two activists and an unnamed official (Krishnan, 11/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.